FS KKR Capital Corp. FSK 深 滬
等待開盤 08-06 09:30:00 美东时间
20.155
+0.075
+0.37%
華盛通- 最 高20.19
- 今 開20.02
- 成交量 178.28万股
- 最 低 19.70
- 昨 收 20.08
- 總市值 56.43亿
- 52周最高 22.70
- 市盈率 靜 9.65
- 換手率 0.64%
- 52周最低 16.60
- 委 比 2.19%
- 總股本 2.80亿
- 歷史最高 22.70
- 量 比 1.42
- 振 幅 2.44%
- 歷史最低 -6.58
- 每 手 1
- 風險率 1.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Alpha Modus Holdings Deploys CashX Financial Services Kiosk At Afia Grocery
Alpha Modus Holdings, Inc. (NASDAQ:AMOD), an AI-powered retail fintech platform, today announced the deployment of the CashX Financial Services Kiosk (FSK) at Afia Grocery, a leading African specialty retailer in
07-08 20:38
Is FS KKR Capital Gaining or Losing Market Support?
FS KKR Capital's (NYSE:FSK) short percent of float has fallen 13.13% since its ...
06-24 03:00
Price Over Earnings Overview: FS KKR Capital
In the current market session, FS KKR Capital Inc. (NYSE:FSK) stock price is at...
06-14 01:00
FS KKR Capital’s Subsidiary Secures $400M Credit Facility
The latest announcement is out from FS KKR Capital ( ($FSK) ). On June 2, 2025,...
06-07 04:50
美股6月收息策略：最高股息率超9%！默沙东、惠普、百事可乐等近90家高分红股如何布局？
最高股息率超13%！默沙东、惠普、百事可乐等近90家美股即将派息；投资者若想赚取股息，可趁未除净适时部署，一文速览派息名单>>
05-31 10:07
The Smart Money Is Buying These 10 Stocks
I got into the investment business on a steady diet of Graham and Whitman. But ...
05-21 04:50
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
05-17 08:44
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
美股大行评级 | 潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
05-10 10:00
Oppenheimer Maintains Perform on FS KKR Capital, Lowers Price Target to $21
Oppenheimer analyst Mitchel Penn maintains FS KKR Capital (NYSE:FSK) with a Perform and lowers the price target from $22 to $21.
05-10 01:24
